首页> 外文期刊>Frontiers in Medicine >Risk Scores and Machine Learning to Identify Patients With Acute Periprosthetic Joints Infections That Will Likely Fail Classical Irrigation and Debridement
【24h】

Risk Scores and Machine Learning to Identify Patients With Acute Periprosthetic Joints Infections That Will Likely Fail Classical Irrigation and Debridement

机译:风险评分和机器学习识别患有急性围髋关节感染的患者,这可能会失败古典灌溉和清除

获取原文
           

摘要

The most preferred treatment for acute periprosthetic joint infection (PJI) is surgical debridement, antibiotics and retention of the implant (DAIR). The reported success of DAIR varies greatly and depends on a complex interplay of several host-related factors, duration of symptoms, the microorganism(s) causing the infection, its susceptibility to antibiotics and many others. Thus, there is a great clinical need to predict failure of the “classical” DAIR procedure so that this surgical option is offered to those most likely to succeed, but also to identify those patients who may benefit from more intensified antibiotic treatment regimens or new and innovative treatment strategies. In this review article, the current recommendations for DAIR will be discussed, a summary of independent risk factors for DAIR failure will be provided and the advantages and limitations of the clinical use of preoperative risk scores in early acute (post-surgical) and late acute (hematogenous) PJIs will be presented. In addition, the potential of implementing machine learning (artificial intelligence) in identifying patients who are at highest risk for failure of DAIR will be addressed. The ultimate goal is to maximally tailor and individualize treatment strategies and to avoid treatment generalization.
机译:最优选的急性心肌细胞接触感染(PJI)的治疗是手术清创,抗生素和植入物(DAIR)的保留。达布尔的成功差异大大变化,取决于几个与宿主相关因素的复杂相互作用,症状持续时间,导致感染的微生物,其对抗生素的易感性以及许多其他宿主。因此,有一个很好的临床需要预测“经典”乳酸程序的失败,以便向最有可能成功的人提供这种外科选择,而且还要鉴定那些可能从更强化的抗生素治疗方案或新的患者受益的患者创新的治疗策略。在本综述文章中,将讨论当前对达尔的建议,将提供达尔失败的独立风险因素的摘要以及早期急性(外科手术后)和晚期急性风险评分的临床使用的优势和局限(血源性)PJI将出现。此外,将解决在识别达尔失败风险的患者中实施机器学习(人工智能)的潜力将得到解决。最终目标是最大程度裁缝和个性化治疗策略,并避免治疗概括。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号